dihexa human clinical trials data Advancing Diversity in Development through Cross-Stakeholder Commitment and Action Unlocking the Potential of Dihexa

Product Specifications Compound: AOD-9604 Class: Synthetic peptide fragment / growth hormone C-terminal analog Origin: C-terminal fragment of human growth hormone (residues 177-191) with N-terminal tyrosine addition Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Weight: ~1815 Da Form: Lyophilized powder Vial Size: 5mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Context AOD-9604 is utilized in research applications involving peptide chemistry , growth hormone fragment research , and cellular research applications

After 812 weeks of daily administration, the hypothalamic-pituitary-somatotroph axis adapts

Members access detailed supplier analyses, community-verified sourcing recommendations, and tools that help researchers navigate the complex research peptide landscape with more confidence

Techniques that help include counting your drinks, slowing down, hydrating and eating food

A 45-year-old at 200 pounds rarely needs the same dose as a 55-year-old at 280 pounds

Methods Cell lines and culture conditions HEK293E (ATCC, CRL-10852) and Jurkat cells (ATCC, TIB-152) were cultured in RPMI media (Gibco, #61870-010) supplemented with 10% fetal bovine serum (FBS) (Sigma, #10500-064) and 1% PenStrep (Sigma, #15140-122)